MENU
+Compare
XTNT
Stock ticker: ASE
AS OF
Nov 13, 04:58 PM (EDT)
Price
$0.67
Change
-$0.05 (-6.94%)
Capitalization
101.07M

XTNT Xtant Medical Holdings Forecast, Technical & Fundamental Analysis

Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures... Show more

XTNT
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for XTNT with price predictions
Nov 12, 2025

XTNT's Stochastic Oscillator is staying in oversold zone for 5 days

The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where XTNT advanced for three days, in of 221 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 199 cases where XTNT Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for XTNT moved out of overbought territory on October 31, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 28 similar instances where the indicator moved out of overbought territory. In of the 28 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Momentum Indicator moved below the 0 level on November 07, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on XTNT as a result. In of 98 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for XTNT turned negative on November 04, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 45 similar instances when the indicator turned negative. In of the 45 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where XTNT declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

XTNT broke above its upper Bollinger Band on October 27, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. XTNT’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.006) is normal, around the industry mean (63.534). P/E Ratio (72.190) is within average values for comparable stocks, (37.086). XTNT's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.687). XTNT has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.019). P/S Ratio (0.798) is also within normal values, averaging (79.919).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. XTNT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.

View a ticker or compare two or three
XTNT
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

XTNT is expected to report earnings to fall 200.00% to 0 cents per share on March 05

Xtant Medical Holdings XTNT Stock Earnings Reports
Q4'25
Est.
$-0.01
Q3'25
Beat
by $0.02
Q2'25
Beat
by $0.03
Q1'25
Beat
by $0.29
Q4'24
Missed
by $0.01
The last earnings report on November 10 showed earnings per share of 0 cents, beating the estimate of 0 cents. With 128.77K shares outstanding, the current market capitalization sits at 101.07M.
A.I. Advisor
published General Information

General Information

a manufacturer of surgical products

Industry MedicalNursingServices

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
664 Cruiser Lane
Phone
+1 406 388-0480
Employees
215
Web
http://www.xtantmedical.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VEMLY57.810.41
+0.71%
Venture Corp., Ltd.
IFLXF0.82N/A
N/A
Imaflex Inc
SONVF267.420.01
N/A
Sonova Holding AG
CODQL0.25N/A
N/A
Coronado Global Res Inc
GRDV0.20N/A
N/A
GOLDEN ROYAL DEVELOPMENT INC.

XTNT and Stocks

Correlation & Price change

A.I.dvisor tells us that XTNT and STRRP have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that XTNT and STRRP's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XTNT
1D Price
Change %
XTNT100%
-4.55%
STRRP - XTNT
31%
Poorly correlated
+2.56%
CVRX - XTNT
28%
Poorly correlated
-3.25%
MEHCQ - XTNT
25%
Poorly correlated
+8.65%
ACRS - XTNT
25%
Poorly correlated
+4.78%
MBOT - XTNT
24%
Poorly correlated
+1.44%
More

Groups containing XTNT

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XTNT
1D Price
Change %
XTNT100%
-4.55%
Medical/Nursing Services
industry (215 stocks)
18%
Poorly correlated
-2.32%
Health Services
industry (422 stocks)
-12%
Poorly correlated
-2.10%